Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome.
about
Somatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalySomatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalyAdvancing Treatment of Pituitary Adenomas through Targeted Molecular Therapies: The Acromegaly and Cushing Disease ParadigmsManagement of acromegaly in Latin America: expert panel recommendationsSomatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegalyFrom somatostatin to octreotide LAR: evolution of a somatostatin analoguePituitary tumors in childhood: update of diagnosis, treatment and molecular genetics.Pharmacotherapy for adults with tumors of the central nervous system.Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation.Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contributionApoptosis: its role in pituitary development and neoplastic pituitary tissue.Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin ReceptorsManagement of aggressive growth hormone secreting pituitary adenomas.Immunohistochemical detection of somatostatin receptor (SSTR) subtypes 2A and 5 in pituitary adenoma from acromegalic patients: good correlation with preoperative response to octreotide.
P2860
Q24188346-D8976A8B-6046-4218-B87B-6780D398E6B2Q24239834-8C98FE6D-AF20-476F-B2B3-C9D68A34F417Q26741707-62395727-BCF8-4B77-9029-97191FA38EB6Q33794388-6E0B56AB-68FC-42EF-87CA-7C4AE892B4E9Q35216414-4E6F52A3-2A34-4254-A167-D94A3D5D3F46Q35228807-9982E935-AF39-45AD-84E9-50035FD41C15Q36919554-4BAD27AB-D331-40CB-9467-57A63D3BBFBDQ37139774-1A9FD53F-98BB-4755-AEB3-8A85A66A46D3Q37353276-41648B33-2B34-4B6F-8C91-9F9404244117Q37425200-FA1BAC4C-4AB5-4A31-8372-9841963ED830Q37528649-DC2AAE78-67F4-41B2-8478-37A2FDEBD390Q37598533-2627A6DA-C766-4EFB-9E18-3A28F62A9201Q38091381-94E90CED-3E93-43C3-B7F9-3E45FD212FEEQ38166623-5D1709E2-9F5F-4CD8-B3BE-07829CB588BAQ38781620-5F81435B-9E7D-40CA-9604-1EF08EA653D1Q46911427-506003DC-C69E-4F55-B0FE-494B378CCC4C
P2860
Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome.
@ast
Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome.
@en
type
label
Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome.
@ast
Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome.
@en
prefLabel
Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome.
@ast
Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome.
@en
P356
P1476
Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome.
@en
P2093
Marcello D Bronstein
P304
P356
10.1159/000094315
P577
2006-01-01T00:00:00Z